This inventor holds 8 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Northwestern University, Centre National De La Recherche Scientifique, Universitéde Strasbourg. Active years: 2011-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Guangzhou, CH (2013)
- Guangzhou, CN (2011 - 2017)
Company Filing History:
7 out of 2,220 
5 out of 5,383 
5 out of 187 
Years Active: 2011-2017
Title: Wenhui Hu: Innovator in Pyridazine Compounds
Introduction
Wenhui Hu is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of chemistry, particularly in the development of novel pyridazine compounds. With a total of 8 patents to his name, his work has implications for various therapeutic applications.
Latest Patents
Wenhui Hu's latest patents focus on pyridazine compounds, compositions, and methods. These inventions relate to novel chemical compounds and their applications in modulating cellular pathways, such as signal transduction pathways. His work aims to provide solutions for the treatment and prevention of inflammatory diseases, including Alzheimer's disease. The methods he has developed are also applicable for research, drug screening, and therapeutic applications.
Career Highlights
Throughout his career, Wenhui Hu has worked with prestigious institutions, including Northwestern University and Université de Strasbourg. His research has garnered attention for its innovative approach to addressing complex medical challenges.
Collaborations
Wenhui Hu has collaborated with notable colleagues, including D Martin Watterson and Linda J Van Eldik. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Wenhui Hu's contributions to the field of chemistry, particularly through his innovative work on pyridazine compounds, highlight his role as a significant inventor. His research continues to pave the way for advancements in medical treatments and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile